Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Osteoporosis Pharmacotherapy
  • CME
  • CE

Credits Available
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Physician Assistants: 0.25 AAPA Category 1 Credits
Released: November 17, 2022 Expiration: November 16, 2023
Start Activity
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Radius Health
person default
E. Michael Lewiecki, MD

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Summarize key features of pharmacologic treatments for osteoporosis and use this information to customize patient treatment

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:


E. Michael Lewiecki, MD

Clinical Assistant Professor of Medicine
Department of Medicine
University of New Mexico School of Medicine
Metabolic Bone Disease
New Mexico Clinical Research & Osteoporosis Center
Albuquerque, New Mexico

E. Michael Lewiecki, MD, FACP, FACE: consultant/advisor/speaker: Amgen; researcher: Radius Health.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except for Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES, as noted below:

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES: consultant: Bayer, Novo Nordisk, Provention Bio, Xeris.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for primary care physicians and advanced practice providers (nurse practitioners/physician assistants/physician associates).


The goal of this program is to improve learners’ competence in screening and treating individuals at risk for osteoporosis and address critical gaps in primary and secondary osteoporotic fracture prevention with pharmacotherapy and healthy lifestyle interventions.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until November 16, 2023. PAs should only claim commensurate with the extent of their participation.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 17, 2022, through November 16, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Osteoporosis Pharmacotherapy
  • CME
  • CE

In this microlearning module, a leading expert reviews osteoporosis pharmacotherapy options and preferred treatments based on patient-specific factors.
person default
E. Michael Lewiecki, MD
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Physician Assistants: 0.25 AAPA Category 1 Credits
Released: November 17, 2022 Expiration: November 16, 2023

Related Content

Expert discussion of the importance of listening and validating your patient’s experience when assessing them for chronic idiopathic constipation, from Clinical Care Options (CCO)

Monica Nandwani, DNP, RN, FNP-BC Released: January 27, 2023

Quick reference guide on the basic and nonpharmacologic management of moderate to severe atopic dermatitis, from Clinical Care Options (CCO)

Robert Sidbury, MD, MPH Jonathan Silverberg, MD, PhD, MPH Released: January 26, 2023

Expert commentary on the treatment of chronic idiopathic constipation, from Clinical Care Options (CCO).

Brooks D. Cash, MD Released: January 19, 2023

Get the latest evidence-based updates on the management of moderate to severe for tweens and teens from Clinical Care Options (CCO).

Robert Sidbury, MD, MPH Jonathan Silverberg, MD, PhD, MPH Released: January 13, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings